Olympus Co. (OTCMKTS:OCPNY – Get Rating) was the recipient of a large decline in short interest in April. As of April 30th, there was short interest totalling 82,800 shares, a decline of 45.7% from the April 15th total of 152,400 shares. Based on an average trading volume of 317,200 shares, the short-interest ratio is currently 0.3 days.
OTCMKTS OCPNY opened at $21.55 on Friday. The company has a debt-to-equity ratio of 0.71, a quick ratio of 1.47 and a current ratio of 1.97. Olympus has a one year low of $16.80 and a one year high of $24.26. The company has a 50-day simple moving average of $18.66 and a 200-day simple moving average of $20.59. The firm has a market capitalization of $28.00 billion, a PE ratio of 26.94, a price-to-earnings-growth ratio of 1.04 and a beta of 0.69.
Separately, Zacks Investment Research cut Olympus from a “hold” rating to a “sell” rating in a research note on Wednesday, April 13th.
Olympus Corporation manufactures and sells precision machineries and instruments worldwide. It operates through four segments: Endoscopic Solutions Business, Therapeutic Solutions Business, Scientific Solutions Business, and Others. The Endoscopic Solutions Business segment offers gastrointestinal and surgical endoscopes, endoscopy system, and repair services.
- Get a free copy of the StockNews.com research report on Olympus (OCPNY)
- The Three Most Upgraded Stocks You Can Buy Now
- MarketBeat: Week in Review 5/9 – 5/13
- Is Electronic Arts (NASDAQ: EA) Suddenly A Safe Haven?
- Beyond Meat Stock Value is Improving
- The Travel Sector Is Getting Upgraded
Receive News & Ratings for Olympus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Olympus and related companies with MarketBeat.com's FREE daily email newsletter.